Development history

yumed Pharmaceutical is officially operational, headquartered in Suzhou, and focuses on providing one-stop services for small molecule drug customers from route development to commercialization, including research and development, production, and registration application.

yumed Pharmaceutical is officially operational, headquartered in Suzhou, and focuses on providing one-stop services for small molecule drug customers from route development to commercialization, including research and development, production, and registration application.

The Suzhou R&D Center and Business Center have been established, with a total area of nearly 3000 square meters of R&D and office space, providing professional services for various product development.

The Suzhou R&D Center and Business Center have been established, with a total area of nearly 3000 square meters of R&D and office space, providing professional services for various product development.

The construction plan for the GMP production base (factory) for raw materials has been launched, covering a total area of 60 acres. It is expected that after completion, more than 150 tons of chemical raw materials can be synthesized.

The construction plan for the GMP production base (factory) for raw materials has been launched, covering a total area of 60 acres. It is expected that after completion, more than 150 tons of chemical raw materials can be synthesized.

Wuhan R&D Center has been established, establishing a 1600 square meter standard synthesis laboratory that can provide API research and compliance declaration, as well as chemical intermediate research and development services.

Wuhan R&D Center has been established, establishing a 1600 square meter standard synthesis laboratory that can provide API research and compliance declaration, as well as chemical intermediate research and development services.

The GMP factory in Changsha, Hunan has been put into operation, with a total of 8000 square meters of raw material drug production base, which can provide API, advanced intermediate production, and CDMO business.

The GMP factory in Changsha, Hunan has been put into operation, with a total of 8000 square meters of raw material drug production base, which can provide API, advanced intermediate production, and CDMO business.